
Certificate purusant to Regulation 74(5) of the SEBI (D&P) Regulations, 2018, for the quarter ended on 30th September, 2025.
Filed with BSE ·

Certificate purusant to Regulation 74(5) of the SEBI (D&P) Regulations, 2018, for the quarter ended on 30th September, 2025.
6ix hasn’t read this filing yet.
Jenburkt Pharmaceuticals Ltd on 6ix
Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.
Follow Jenburkt Pharmaceuticals